These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Mason JW; Winkle RA Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781 [TBL] [Abstract][Full Text] [Related]
23. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia]. Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133 [TBL] [Abstract][Full Text] [Related]
25. Role of programmed stimulation in assessing vulnerability to ventricular arrhythmias. Horowitz LN; Spielman SR; Greenspan AM; Josephson ME Am Heart J; 1982 Apr; 103(4 Pt 2):604-10. PubMed ID: 7064803 [TBL] [Abstract][Full Text] [Related]
26. [Continuous ventricular tachyarrhythmia in patients without detectable organic heart disease: clinical and electrophysiologic findings]. Schöls W; Brachmann J; Schmitt C; Waldecker B; Kübler W Z Kardiol; 1989 Dec; 78(12):790-6. PubMed ID: 2623922 [TBL] [Abstract][Full Text] [Related]
27. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Keren G; Miura DS; Somberg JC Am Heart J; 1984 Apr; 107(4):638-43. PubMed ID: 6702556 [TBL] [Abstract][Full Text] [Related]
28. Selection of antiarrhythmic drugs based on electrophysiologic studies. Prystowsky EN Cardiovasc Clin; 1985; 16(1):239-59. PubMed ID: 3837691 [No Abstract] [Full Text] [Related]
29. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. Lemery R; Brugada P; Bella PD; Dugernier T; van den Dool A; Wellens HJ Circulation; 1989 May; 79(5):990-9. PubMed ID: 2713978 [TBL] [Abstract][Full Text] [Related]
30. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. Winters SL; Cohen M; Greenberg S; Stein B; Curwin J; Pe E; Gomes JA J Am Coll Cardiol; 1991 Oct; 18(4):937-43. PubMed ID: 1894867 [TBL] [Abstract][Full Text] [Related]
31. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. Waxman HL; Buxton AE; Sadowski LM; Josephson ME Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803 [TBL] [Abstract][Full Text] [Related]
32. [Anti-arrhythmia and pro-arrhythmia effects of oral cibenzoline therapy in sustained ventricular tachycardia]. Hoffmann E; Bach P; Haberl R; Mattke S; Steinbeck G Z Kardiol; 1992 Jul; 81(7):378-84. PubMed ID: 1509795 [TBL] [Abstract][Full Text] [Related]
33. Anatomic and electrophysiologic correlates of ventricular tachycardia requiring left ventricular stimulation. Robertson JF; Cain ME; Horowitz LN; Spielman SR; Greenspan AM; Waxman HL; Josephson ME Am J Cardiol; 1981 Aug; 48(2):263-8. PubMed ID: 7270435 [TBL] [Abstract][Full Text] [Related]
35. Uses and limitations of electrophysiology studies for the selection of antiarrhythmic therapy. Kowey PR; Friehling TD Pacing Clin Electrophysiol; 1986 Mar; 9(2):231-47. PubMed ID: 2419873 [No Abstract] [Full Text] [Related]
36. Selection of optimal drug treatment of ventricular tachycardia by programmed electrical stimulation of the heart. Breithardt G; Borggrefe M; Seipel L Ann N Y Acad Sci; 1984; 427():49-66. PubMed ID: 6378018 [No Abstract] [Full Text] [Related]
37. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503 [TBL] [Abstract][Full Text] [Related]
38. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation. Kim SG; Felder SD; Waspe LE; Fisher JD Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910 [TBL] [Abstract][Full Text] [Related]
39. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram. Steinbeck G; Bach P; Haberl R J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368 [TBL] [Abstract][Full Text] [Related]
40. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation. Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]